One of the hallmarks of Parkinson's disease (PD) is the accumulation in the brain of a protein known as alpha-synuclein. For more than two decades, alpha-synuclein has been a focal point of attention for researchers, clinicians ...
Jun 9, 2022
0
78
In studies in mice, Johns Hopkins Medicine researchers say they have identified a chemical compound that stops the final events in the pathway linked to the death of brain cells in Parkinson's disease. Results of the experiments, ...
Jun 1, 2022
0
112
In studies with mouse and human tissue, as well as live mice, Johns Hopkins Medicine researchers report that a snag in the normal process of cleaning up broken DNA in brain cells may hasten the progression of Parkinson's ...
May 19, 2022
0
87
Parkinson's disease is perhaps best known for its movement-related symptoms, particularly tremors and stiffness.
May 4, 2022
0
61
Parkinson's disease and Lewy body dementia belong to a family of neurodegenerative disorders called synucleinopathies because they are caused by the pathological accumulation of protein alpha-synuclein into structures called ...
Apr 29, 2022
0
78
A new study, published in the journal Paediatric Research, provides evidence that the number of school-age children admitted to hospital with coronavirus did not rise significantly in the second wave of the disease when compared ...
Apr 22, 2022
0
14
A new study reports that immune cell responses to bacteria affect the intrinsic excitability of rat neuronal subtypes differently. The findings have implications for neural network control, including irregularities that lead ...
Apr 19, 2022
0
7
Yale scientists have discovered that a protein known as augmentor-alpha regulates body weight in mice, an insight that could lead to new treatments for metabolic disorders.
Apr 11, 2022
0
460
Identifying genetic risk factors for Alzheimer's disease is essential if we are to improve our understanding and treatment of it. Progress in human genome analysis along with genome-wide association studies are now leading ...
Apr 4, 2022
0
84
New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23–26 April), suggests that the symptoms connected to long COVID could be different ...
Mar 25, 2022
0
31
